These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
383 related items for PubMed ID: 31480051
1. Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/β-Catenin Pathway and Epithelial-Mesenchymal Transition. Wei C, Jing J, Zhang Y, Fang L. Pharmacology; 2019; 104(5-6):312-319. PubMed ID: 31480051 [Abstract] [Full Text] [Related]
2. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X, Yan W, Dai Z, Gao X, Ma Y, Xu Q, Jiang J, Zhang S. Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851 [Abstract] [Full Text] [Related]
3. Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition. Wang P, Gao XY, Yang SQ, Sun ZX, Dian LL, Qasim M, Phyo AT, Liang ZS, Sun YF. Drug Des Devel Ther; 2019; 13():2235-2247. PubMed ID: 31371920 [Abstract] [Full Text] [Related]
4. Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β-catenin pathway. Huang Y, Zhao K, Hu Y, Zhou Y, Luo X, Li X, Wei L, Li Z, You Q, Guo Q, Lu N. Mol Carcinog; 2016 Nov; 55(11):1598-1612. PubMed ID: 26387984 [Abstract] [Full Text] [Related]
5. β-ionone Inhibits Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Cells by Negatively Regulating the Wnt/β-Catenin Pathway. Fang Q, Que T, Liu B, Dan W, Wei Y, Ren B, Fan Y, Hou T, Zeng J. Front Biosci (Landmark Ed); 2022 Dec 28; 27(12):335. PubMed ID: 36624947 [Abstract] [Full Text] [Related]
6. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Jiang YG, Luo Y, He DL, Li X, Zhang LL, Peng T, Li MC, Lin YH. Int J Urol; 2007 Nov 28; 14(11):1034-9. PubMed ID: 17956532 [Abstract] [Full Text] [Related]
7. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin. Chen L, Mai W, Chen M, Hu J, Zhuo Z, Lei X, Deng L, Liu J, Yao N, Huang M, Peng Y, Ye W, Zhang D. Pharmacol Res; 2017 Sep 28; 123():130-142. PubMed ID: 28712972 [Abstract] [Full Text] [Related]
8. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway. Hu C, Dong T, Li R, Lu J, Wei X, Liu P. Oncol Rep; 2016 Apr 28; 35(4):2027-34. PubMed ID: 26820690 [Abstract] [Full Text] [Related]
9. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling. Chen Y, Chen ZY, Chen L, Zhang JY, Fu LY, Tao L, Zhang Y, Hu XX, Shen XC. Biochem Pharmacol; 2019 Aug 28; 166():33-45. PubMed ID: 31071331 [Abstract] [Full Text] [Related]
10. 2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer. Wu S, Huang J, Hui K, Yue Y, Gu Y, Ning Z, Wang X, He D, Wu K. Oncol Rep; 2018 Nov 28; 40(5):2836-2843. PubMed ID: 30226607 [Abstract] [Full Text] [Related]
11. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. He YM, Xiao YS, Wei L, Zhang JQ, Peng CH. J Cell Biochem; 2018 Jul 28; 119(7):5308-5323. PubMed ID: 29274277 [Abstract] [Full Text] [Related]
12. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. Yang Z, Ji L, Jiang G, Liu R, Liu Z, Yang Y, Ma Q, Zhao H. Biosci Trends; 2018 Jul 28; 12(1):40-46. PubMed ID: 29553100 [Abstract] [Full Text] [Related]
13. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers. Hseu YC, Chang GR, Pan JY, Rajendran P, Mathew DC, Li ML, Liao JW, Chen WT, Yang HL. J Cell Physiol; 2019 Apr 28; 234(4):4125-4139. PubMed ID: 30146779 [Abstract] [Full Text] [Related]
14. The peptide mimicking small extracellular ring domain of CD82 inhibits epithelial-mesenchymal transition by downregulating Wnt pathway and upregulating hippo pathway. He X, Huang X, Wang C, Luan M, Li Y, Ma X, Ma K. Biochem Biophys Res Commun; 2020 Dec 10; 533(3):338-345. PubMed ID: 32958256 [Abstract] [Full Text] [Related]
15. Effects of plant-based medicinal food on postoperative recurrence and lung metastasis of gastric cancer regulated by Wnt/β-catenin-EMT signaling pathway and VEGF-C/D-VEGFR-3 cascade in a mouse model. Tian L, Chen X, Cao L, Zhang L, Chen J. BMC Complement Med Ther; 2022 Sep 02; 22(1):233. PubMed ID: 36056333 [Abstract] [Full Text] [Related]
16. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition. Zhang B, Yang Y, Shi X, Liao W, Chen M, Cheng AS, Yan H, Fang C, Zhang S, Xu G, Shen S, Huang S, Chen G, Lv Y, Ling T, Zhang X, Wang L, Zhuge Y, Zou X. Cancer Lett; 2015 Jan 28; 356(2 Pt B):704-12. PubMed ID: 25449432 [Abstract] [Full Text] [Related]
17. The metastasis suppressor CD82/KAI1 represses the TGF-β 1 and Wnt signalings inducing epithelial-to-mesenchymal transition linked to invasiveness of prostate cancer cells. Lee MS, Lee J, Kim YM, Lee H. Prostate; 2019 Sep 28; 79(12):1400-1411. PubMed ID: 31212375 [Abstract] [Full Text] [Related]
18. Litchi seed extracts diminish prostate cancer progression via induction of apoptosis and attenuation of EMT through Akt/GSK-3β signaling. Guo H, Luo H, Yuan H, Xia Y, Shu P, Huang X, Lu Y, Liu X, Keller ET, Sun D, Deng J, Zhang J. Sci Rep; 2017 Jan 30; 7():41656. PubMed ID: 28134352 [Abstract] [Full Text] [Related]
19. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells. Park JH, Kwon HY, Sohn EJ, Kim KA, Kim B, Jeong SJ, Song JH, Koo JS, Kim SH. Pharmacol Rep; 2013 Jan 30; 65(5):1366-74. PubMed ID: 24399733 [Abstract] [Full Text] [Related]
20. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT). Sun Y, Gao X, Wu P, Wink M, Li J, Dian L, Liang Z. Phytomedicine; 2019 Oct 30; 63():153015. PubMed ID: 31302315 [Abstract] [Full Text] [Related] Page: [Next] [New Search]